An outside of the united states (ous) customer contacted a siemens customer care center (ccc).Quality controls (qc) recovered in range and no instrument or application issue was identified.The pathromtin sl instructions for use (ifu) indicates "pathromtin sl must be gently inverted (5 to 8 times) to mix before first use".Sedimentation of the pathromtin sl reagent cannot be ruled out as a potential cause of the event.The cause of the event is unknown.The reagent is performing according to specifications.No further evaluation of this device is required.The pathromtin sl (rilibak) reagent is not marketed in the united states (us).This mdr is filed for the us similar reagent (pathromtin sl reagent).The pathromtin sl reagent marketed in the us has catalog number: 10446066, unique device identifier (b)(4), and the pma/510(k) k955450.
|
Two falsely elevated activated partial thromboplastin time (aptt) results were obtained on two patient samples on a sysmex cs-5100 system using pathromtim sl (rilibak) reagent.The discordant results were not reported to the physician(s).The sample from patient 1 was repeated for aptt using a new reagent vial on the same system, and the sample from patient 2 was repeated for aptt using an alternate sysmex cs-5100 system.The repeat aptt results for both patients recovered lower.The repeat results were reported, as the correct results, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the elevated aptt results.
|